Cargando…

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase

Parkinson’s disease (PD) is an aging-related disease and the second most common neurodegenerative disease after Alzheimer’s disease. The main symptoms of PD are movement disorders accompanied with deficiency of neurotransmitter dopamine (DA) in the striatum due to cell death of the nigrostriatal DA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagatsu, Toshiharu, Nakashima, Akira, Watanabe, Hirohisa, Ito, Shosuke, Wakamatsu, Kazumasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029562/ https://www.ncbi.nlm.nih.gov/pubmed/35456994 http://dx.doi.org/10.3390/ijms23084176

Ejemplares similares

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
por: Nagatsu, Toshiharu, et al.
Publicado: (2023)

Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus
por: Wakamatsu, Kazumasa, et al.
Publicado: (2015)

Chemical Reactivities of ortho-Quinones Produced in Living Organisms: Fate of Quinonoid Products Formed by Tyrosinase and Phenoloxidase Action on Phenols and Catechols
por: Ito, Shosuke, et al.
Publicado: (2020)

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
por: Riederer, Peter, et al.
Publicado: (2023)

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
por: Carballo-Carbajal, Iria, et al.
Publicado: (2019)

Reduction of the Nitro Group to Amine by Hydroiodic Acid to Synthesize o-Aminophenol Derivatives as Putative Degradative Markers of Neuromelanin
por: Wakamatsu, Kazumasa, et al.
Publicado: (2014)

Neuromelanins of Human Brain Have Soluble and Insoluble Components with Dolichols Attached to the Melanic Structure
por: Engelen, Mireille, et al.
Publicado: (2012)

The Oxidation of Equol by Tyrosinase Produces a Unique Di-ortho-Quinone: Possible Implications for Melanocyte Toxicity
por: Tanaka, Hitomi, et al.
Publicado: (2021)

Application of Neuromelanin MR Imaging in Parkinson Disease
por: He, Naying, et al.
Publicado: (2022)

Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes
por: Wulf, Maximilian, et al.
Publicado: (2022)

Nigrosome and Neuromelanin Imaging as Tools to Differentiate Parkinson's Disease and Parkinsonism
por: Biswas, Deblina, et al.
Publicado: (2022)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

The catecholamine system in health and disease —Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes—
por: Nagatsu, Toshiharu
Publicado: (2006)

Biochemical Mechanism of Rhododendrol-Induced Leukoderma
por: Ito, Shosuke, et al.
Publicado: (2018)

Recent Advances in Characterization of Melanin Pigments in Biological Samples
por: Wakamatsu, Kazumasa, et al.
Publicado: (2023)

Tyrosinase Depletion Prevents the Maturation of Melanosomes in the Mouse Hair Follicle
por: Paterson, Elyse K., et al.
Publicado: (2015)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

Tyrosinase-induced neuromelanin accumulation triggers rapid dysregulation and degeneration of the mouse locus coeruleus
por: Iannitelli, Alexa F., et al.
Publicado: (2023)

Coumarin-Based Compounds as Inhibitors of Tyrosinase/Tyrosine Hydroxylase: Synthesis, Kinetic Studies, and In Silico Approaches
por: Nunes, Jéssica Alves, et al.
Publicado: (2023)

Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review
por: Tamura, Yasuaki, et al.
Publicado: (2022)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
por: Liu, Qiang, et al.
Publicado: (2023)

Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
por: Pizarro-Galleguillos, Benjamin Matis, et al.
Publicado: (2022)

The Oxidative Pathway to Dopamine–Protein Conjugates and Their Pro-Oxidant Activities: Implications for the Neurodegeneration of Parkinson’s Disease
por: Wakamatsu, Kazumasa, et al.
Publicado: (2019)

The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
por: Zhou, Zhi Dong, et al.
Publicado: (2022)

The protective and toxic role of neuromelanins in brain aging and Parkinson’s disease
por: Zecca, Luigi, et al.
Publicado: (2015)

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
por: Biondetti, Emma, et al.
Publicado: (2021)

A Rare Novel Deletion of the Tyrosine Hydroxylase Gene in Parkinson Disease
por: Bademci, Güney, et al.
Publicado: (2010)

The expression and significance of tyrosine hydroxylase in the brain tissue of Parkinsons disease rats
por: Chen, Yuan, et al.
Publicado: (2017)

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
por: Kawahata, Ichiro, et al.
Publicado: (2020)

Effects of Aging on Hair Color, Melanosomes, and Melanin Composition in Japanese Males and Their Sex Differences
por: Itou, Takashi, et al.
Publicado: (2022)

Effects of Aging on Hair Color, Melanosome Morphology, and Melanin Composition in Japanese Females
por: Itou, Takashi, et al.
Publicado: (2019)

Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)

Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease
por: Sulzer, David, et al.
Publicado: (2018)

Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
por: Ben Bashat, Dafna, et al.
Publicado: (2022)

Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role
por: Zucca, Fabio A., et al.
Publicado: (2022)

Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?
por: Okuzumi, A., et al.
Publicado: (2019)

Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker
por: Gaurav, Rahul, et al.
Publicado: (2021)

In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
por: Gonzalez-Sepulveda, Marta, et al.
Publicado: (2023)

Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development
por: Wakamatsu, Kazumasa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lt01m97004uddkpmjmf5j68mca